Delta Financial Group, Inc. Pfizer Inc Transaction History

Delta Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $8,310 - $9,543	-321 Reduced 0.31%	101,791 $2.83 Million
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $51,371 - $66,726	-1,966 Reduced 1.89%	102,112 $2.94 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $3.34 Million - $3.9 Million	104,078 New	104,078 $3.45 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $116,318 - $151,429	2,953 Added 2.89%	105,080 $4.29 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $4.26 Million - $5.57 Million	102,127 New	102,127 $5.22 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Delta Financial Group, Inc. with notifications on news.